Rethinking TREM2 as a target for Alzheimer’s disease after the INVOKE-2 trial failure

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{149fd00940fc451c95d27f4cdc36aed8,

title = "Rethinking TREM2 as a target for Alzheimer{\textquoteright}s disease after the INVOKE-2 trial failure",

author = "Marco Colonna and Holtzman, \{David M.\}",

year = "2025",

month = oct,

doi = "10.1038/s41591-025-03816-2",

language = "English",

volume = "31",

pages = "3217--3218",

journal = "Nature medicine",

issn = "1078-8956",

number = "10",

}

TY - JOUR

T1 - Rethinking TREM2 as a target for Alzheimer’s disease after the INVOKE-2 trial failure

AU - Colonna, Marco

AU - Holtzman, David M.

PY - 2025/10

Y1 - 2025/10

UR - https://www.scopus.com/pages/publications/105009553210

U2 - 10.1038/s41591-025-03816-2

DO - 10.1038/s41591-025-03816-2

M3 - Letter

C2 - 40603729

AN - SCOPUS:105009553210

SN - 1078-8956

VL - 31

SP - 3217

EP - 3218

JO - Nature medicine

JF - Nature medicine

IS - 10

ER -